of the 125 evaluable patient trials , postoperative wound infection or intra-abdominal sepsis developed in 14/29 ( 48 % ) of placebo controls , 8/24 ( 33 % ) cefazolin , 7/37 ( 19 % ) cefoxitin , and in 2/35 ( 6 % ) of cefotaxime recipients .
C0038941
postoperative
C0007557
cefoxitin